Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial

BACKGROUND: Standard insulin infusion sets (IISs) are to be replaced every 2 to 3 days to avoid complications and diabetic ketosis due to set failure. This pivotal trial evaluated the safety and performance of a new extended-wear infusion set (EIS) when used for 7 days by adults with type 1 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Brazg, Ron, Garg, Satish K., Bhargava, Anuj, Thrasher, James R., Latif, Kashif, Bode, Bruce W., Bailey, Timothy S., Horowitz, Barry S., Cavale, Arvind, Kudva, Yogish C., Kaiserman, Kevin B., Grunberger, George, Reed, John Chip, Chattaraj, Sarnath, Zhang, Gina, Shin, John, Chen, Vivian, Lee, Scott W., Cordero, Toni L., Rhinehart, Andrew S., Vigersky, Robert A., Buckingham, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353978/
https://www.ncbi.nlm.nih.gov/pubmed/35263188
http://dx.doi.org/10.1089/dia.2021.0540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353978/
https://www.ncbi.nlm.nih.gov/pubmed/35263188
http://dx.doi.org/10.1089/dia.2021.0540

Ejemplares similares